Stay updated on Safety & Efficacy of FG-3019 in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of FG-3019 in IPF Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Removed the Interstitial lung disease 2 entry and the Genetic and Rare Diseases Information Center resources from the page navigation.
    Difference
    0.1%
    Check dated 2026-03-27T23:59:42.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.0 updated, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T20:08:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:52:11.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. The page content and study details appear unchanged.
    Difference
    0.0%
    Check dated 2026-02-13T12:41:10.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:22:07.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Sponsor information updated: FibroGen was replaced by Kyntra Bio as the sponsor/responsible party in the study record.
    Difference
    0.1%
    Check dated 2026-01-22T09:46:35.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of FG-3019 in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of FG-3019 in IPF Clinical Trial page.